Mermaid-1: A Phase Iii Study Of Adjuvant Durvalumab Plus Chemotherapy In Resected Nsclc Patients With Mrd Plus Post-Surgery
JOURNAL OF THORACIC ONCOLOGY（2021）
关键词
adjuvant therapy, minimal residual disease, PD-L1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要